购物车
- 全部删除
- 您的购物车当前为空
SIRT5 inhibitor7 (compound 58) 是一种底物竞争性且选择性的SIRT5抑制剂,展现出抗炎活性。它在调节蛋白质琥珀酰化和抑制促炎细胞因子释放方面具有潜在的肾功能保护效果。此外,在LPS和CLP诱导的脓毒症相关急性肾损伤小鼠模型中,SIRT5 inhibitor7已证实具备体内有效性。
SIRT5 inhibitor7 (compound 58) 是一种底物竞争性且选择性的SIRT5抑制剂,展现出抗炎活性。它在调节蛋白质琥珀酰化和抑制促炎细胞因子释放方面具有潜在的肾功能保护效果。此外,在LPS和CLP诱导的脓毒症相关急性肾损伤小鼠模型中,SIRT5 inhibitor7已证实具备体内有效性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 11,700 | 8-10周 | |
50 mg | ¥ 15,300 | 8-10周 | |
100 mg | ¥ 19,500 | 8-10周 |
产品描述 | SIRT5 inhibitor 7 (compound 58), a selective and substrate-competitive SIRT5 inhibitor, exhibits anti-inflammatory properties by modulating protein succinylation and attenuating pro-inflammatory cytokine release. It demonstrates renal protective effects and is active in vivo, showing efficacy in AKI mouse models subjected to lipopolysaccharide (LPS) and cecal ligation/perforation (CLP)-induced sepsis-related acute kidney injury [1]. |
分子量 | 582.12 |
分子式 | C28H32ClN7O3S |
CAS No. | 2951090-00-7 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容